US News

Long COVID risk no lower with breakthrough infection; COVID-19 survival improves for European cancer patients

Published by
Reuters

By Nancy Lapid (Reuters) – The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review. Long COVID risk not lower after breakthrough infection COVID-19 vaccines are highly effective in protecting against serious illness, but they do not protect against “long COVID” in people who become infected despite vaccination, new data show. For six months, researchers tracked 9,479 vaccinated individuals diagnosed with COVID-19 and about the same number of infected patients who…

Read More

Facebook Comments

Check Also

Evergrande Default Imminent With No Payment On Deadline Day

China Evergrande Group (HKG:3333) is on the brink ...

Archives